Chikungunya Virus Infection Clinical Trials

30 clinical trials for Chikungunya Virus Infection across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• VLA1553-403 Pregnancy Surveillance Study — RECRUITING
• Observational Study to Assess the Effectiveness of VLA1553 Vaccine in Preventing Chikungunya During a Pilot Vaccination Strategy in Brazil — RECRUITING
• Against Chikungunya Virus and Neonatal Infection — RECRUITING · NA
• Xpert® Tropical Fever Test on GeneXpert® Edge X System — RECRUITING
• Real-world Effectiveness, Safety and Immunogenicity of Chikungunya Vaccination in Populations at Risk of Severe or Complicated Forms: Prospective Study in La Réunion — RECRUITING · PHASE4
• A Phase 2 Clinical Trial of VLA1553 in Healthy Children Aged 1 to 11 Years — COMPLETED · PHASE2
• Long-term Follow-up Study to Evaluate Safety and Immunogenicity of CHIKV VLP Single or Booster Vaccination — ACTIVE_NOT_RECRUITING · PHASE3
• Prospective Safety Cohort Study After VLA1553 Vaccination in Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in Brazil — ACTIVE_NOT_RECRUITING
• Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine (VLA1553) — ACTIVE_NOT_RECRUITING · PHASE3
• A Phase I Study of PepGNP-ChikV in Healthy Volunteers — NOT_YET_RECRUITING · PHASE1
• Assessment of Chikungunya Virus Seroprevalence Before VLA1553 Vaccination in the Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in Brazil — ACTIVE_NOT_RECRUITING
• Phase 1 Study of SAR440894 vs Placebo — COMPLETED · PHASE1
• A Trial to Evaluate the Safety and Immunogenicity of VLA1553 in Healthy Children — WITHDRAWN · PHASE3
• Chikungunya Virus Detection in Semen — NOT_YET_RECRUITING · NA
• Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases — NOT_YET_RECRUITING · NA
• A Clinical Phase 3 Trial of VLA1553 in Adult Participants with Human Immunodeficiency Virus (HIV) — WITHDRAWN · PHASE3
• Consequences of a Maternal-fetal Chikungunya Virus Infection — COMPLETED · NA
• Study to Demonstrate Consistency of Three Lots of a Live-attenuated Chikungunya Virus Vaccine Candidate in Healthy Adults — COMPLETED · PHASE3
• Trial of a Chikungunya Vaccine, PXVX0317 CHIKV-VLP, in Healthy Adults — COMPLETED · PHASE2
• Pivotal Study to Evaluate Safety and Immunogenicity of a Live-Attenuated Chikungunya Virus Vaccine Candidate in Adults — COMPLETED · PHASE3
• Chikungunya Vaccine (V184) Study in Previously Exposed Adults (V184-006) — COMPLETED · PHASE2
• Impact of Wolbachia Deployment on Arboviral Disease Incidence in Medellin and Bello, Colombia — COMPLETED
• Phase II Study to Evaluate Safety and Immunogenicity of a Chikungunya Vaccine — COMPLETED · PHASE2
• Safety, Tolerability and Long-term Immunogenicity of Different Formulations of a Chikungunya Vaccine (V184-005) — COMPLETED · PHASE2
• Phase I Trial of Measles Vectored Chikungungya Vaccine — COMPLETED · PHASE1
• Trial for Safety and Immunogenicity of a Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults — COMPLETED · PHASE2
• Yoga for Chronic Chikungunya — TERMINATED · NA
• Seroprevalence of Chikungunya at the End of the First Chikungunya Outbreak in the French Antilles Within a Sample of Patients Treated for a HIV Infection — COMPLETED
• Chikungunya Virus Vaccine Trial in Healthy Adults — COMPLETED · PHASE1
• Clinical Evaluation of Anti-CHIKV Hyperimmune Intravenous Immunoglobulins — OTHER · PHASE1

Refine this search